Clinical trial
SHIELD II Clinical Investigation
NCT02468778 · Abbott Medical Devices, Industry · Terminated
Key facts
| NCT number | NCT02468778 |
|---|---|
| Title | SHIELD II Clinical Investigation |
| Official title | Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II) |
| Acronym | SHIELD II |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | HeartMate PHP, Any Abiomed Impella® device approved for use in high-risk PCI |
| Enrollment | 54 |
| Start date | Aug 1, 2015 |
| Primary completion | May 17, 2021 |
| Completion | May 17, 2021 |
| First posted | Jun 11, 2015 |
| Last update posted | Jun 28, 2022 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: